BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8819075)

  • 1. Terminal transferase expression in the differential diagnosis of acute leukemias. Eastern Cooperative Oncology Group.
    Meenan B; Heavey C; Lichtenstein A; Andersen J; Paietta E
    Leuk Lymphoma; 1996 Jul; 22(3-4):265-9. PubMed ID: 8819075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
    Paietta E; Meenan B; Heavey C; Thomas D
    Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
    Tang YM
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, rapid, multiparametric approach for flow cytometric analysis of intranuclear terminal deoxynucleotidyl transferase.
    Roma AO; Kutok JL; Shaheen G; Dorfman DM
    Am J Clin Pathol; 1999 Sep; 112(3):343-8. PubMed ID: 10478139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
    Paietta E; Racevskis J; Bennett JM; Wiernik PH
    Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of terminal deoxynucleotidyl transferase.
    Almasri NM; Iturraspe JA; Benson NA; Chen MG; Braylan RC
    Am J Clin Pathol; 1991 Mar; 95(3):376-80. PubMed ID: 1996546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies.
    Bodner SM; Casavant CH; McHugh TM; Stites DP
    Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of terminal deoxynucleotidyl transferase (TdT) by flow cytometry in leukemic disorders.
    Bardales RH; Carrato A; Fleischer M; Schwartz MK; Koziner B
    J Histochem Cytochem; 1989 Apr; 37(4):509-13. PubMed ID: 2647840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoalkaline phosphatase labeling of terminal transferase in hematologic samples.
    Erber WN; Mason DY
    Am J Clin Pathol; 1987 Jul; 88(1):43-50. PubMed ID: 3300265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
    Orazi A; Cattoretti G; John K; Neiman RS
    Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
    Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
    J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia.
    Drach J; Gattringer C; Huber H
    Br J Haematol; 1991 Jan; 77(1):37-42. PubMed ID: 1998595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential TdT expression in acute leukemia by flow cytometry: a quantitative study.
    Farahat N; Lens D; Morilla R; Matutes E; Catovsky D
    Leukemia; 1995 Apr; 9(4):583-7. PubMed ID: 7723388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
    Valmary S; Danjoux M; Delsol G; Brousset P
    Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal transferase in leukemias by flow cytometry.
    Loftin KC; Reuben JM; Dalton W; Hersh EM; Sujansky D
    Diagn Immunol; 1986; 4(3):165-9. PubMed ID: 3460728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
    Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of terminal deoxynucleotidyl transferase in acute leukemias using monoclonal antibodies directed against native and denatured sites.
    Lanham GR; Bollum FJ; Stass SA
    Am J Clin Pathol; 1986 Jul; 86(1):88-91. PubMed ID: 3460324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.